Surgical Management of Intracerebral Hemorrhage: New Light on the Horizon?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 39758006.
- Also identified by DOI 10.1161/STROKEAHA.124.047467.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
After 30 years of disappointment, 2 randomized controlled trials investigating the effect of neurosurgical treatment on functional outcome in patients with intracerebral hemorrhage were published in 2024. The ENRICH trial (Early Minimally Invasive Removal of Intracerebral Hemorrhage) studied the efficacy of early minimally invasive hematoma removal in patients with lobar or anterior basal ganglia intracerebral hemorrhage, whereas the SWITCH trial investigated the effect of decompressive craniectomy without hematoma removal in severe deep intracerebral hemorrhage. In this critique article, we will discuss the main findings of these trials, their implications and future perspectives.
Medical subject headings
- Cerebral Hemorrhage
- Decompressive Craniectomy
- Neurosurgical Procedures